Summary
The Southeast Essex AF group
consists of commissioners, CCG leads from primary care and champions from
stroke, cardiology, clinical pharmacy, haematology and anticoagulation services
at Southend Hospital. Formed in 2010, the group achievements include reviewing
local arrangements for use of antithrombotic therapies in atrial fibrillation
and then developing policies for the integration of NOACs into care pathways. It
has also provided education about why not to use aspirin for stroke prevention,
as well as on AF and anticoagulation/NOACs. The group also delivered a NOAC
clinic to assess patients with poor time-in-therapeutic range, allowing
patients to be actively involved in decision making about their anticoagulant
treatment options.
Challenge
The Southeast Essex AF group
was created with a focus of improving anticoagulation and introducing NOACs
into standard clinical care. A large proportion (up to 80%) of potentially
suitable patients were not switched to a NOAC (where appropriate), putting them
at potentially increased risk of stroke.
Objectives
To make NOACs available for
prescribing within their licensed indications and included in the local
formularies resulting in appropriate but effective use across both Southend and
Castlepoint & Rochford CCGs. To target groups in whom NOACs should
especially be considered. To reduce serious adverse events in patients treated
with oral anticoagulants.
Back to the top